Richard Chin, President and CEO, 10% Owner at Kindred Biosciences, Inc. (KIN), sold 1,930 shares at $10.01 ($19K) on 2018-05-07, disclosed to the SEC on 2018-05-09.
Scheduled sale ($19k) by President and CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.01 | 1,730 | $17K | 89.6% |
| 2 | $10.00 | 200 | $2K | 10.4% |
| Total | $10.01 avg | 1,930 | $19K | 100% |
| Filing → |
| KIN | SELL | 2021-06-17 | $367K | — | Filing → |
| KIN | SELL | 2019-01-04 | $423K | — | Filing → |
| KIN | SELL | 2018-12-04 | $531K | — | Filing → |